Inactive Instrument
BiVictriX Therapeutics plc Stock
Stocks
BVX
GB00BNXH3K91
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +17.65% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
CEO | Chief Executive Officer | 39 | 2015-12-31 |
Adrian Howd
DFI | Director of Finance/CFO | 54 | 2023-10-02 |
Alison Halsall
SEC | Corporate Secretary | - | 2023-10-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Tiffany Thorn
BRD | Director/Board Member | 39 | 2015-12-31 |
Susan Lowther
BRD | Director/Board Member | 67 | 2021-09-21 |
William Paris
BRD | Director/Board Member | 75 | 2021-09-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/2/24 | Buy | Director | 20,000 | 0.0242% | ||
| 9/2/24 | Sell | Director | 20,000 | 0.0242% | ||
| 8/13/24 | Free | Executive/Senior Manager | 320,000 | 0.3878% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +17.65% | +33.33% | - | - | 10.49M | |
| +0.66% | -2.28% | +1.91% | +19.70% | 48.42B | |
| +0.90% | -0.70% | +460.88% | +581.30% | 43.66B | |
| +3.38% | -0.23% | +8.13% | +80.67% | 39.51B | |
| +0.33% | -0.85% | +23.85% | +9.97% | 38.95B | |
| -0.50% | +0.85% | +20.60% | +58.18% | 32.61B | |
| -0.98% | -3.23% | - | - | 16.32B | |
| -0.25% | -2.06% | +26.35% | +126.36% | 16.15B | |
| -0.71% | -0.11% | +3.89% | +27.66% | 14.16B | |
| +0.94% | +4.70% | +78.74% | +38.66% | 13.37B | |
| Average | +2.19% | -0.35% | +78.04% | +117.81% | 29.24B | |
| Weighted average by Cap. | +0.78% | -0.62% | +95.90% | +140.81% |
Employees
-
